Global Learning Collaborative and National Comprehensive Cancer Network Announce Collaboration to Improve Global Cancer Care through Continuing Medical Education Initiatives
Collaboration to deliver a multi-format, multi-disciplinary, and multi-regional educational initiative for clinicians and patient caregivers alike
Fort Washington, PA | November 24, 2021
The Global Learning Collaborative (GLC) and the National Comprehensive Cancer Network® (NCCN®)—an alliance of leading cancer centers in the United States—today announced a new collaboration focusing on advancing global cancer care through a comprehensive suite of education initiatives.
Leveraging the latest evidence and expert consensus, GLC and NCCN will develop a much-needed digital education initiative to address unmet needs of clinicians who treat patients with cancer, and to ensure availability of important patient resources for these patients and their caregivers. The initiative is multi-format, multi-disciplinary, and multi-regional, creating an immersive digital landscape that will improve clinicians’ knowledge, competence, and skills across multiple tumor settings.
“This initiative will help clinicians stay up to date through innovative CME designed for the global care team.”
“Clinicians report they struggle to stay current with the rapidly expanding landscape of cancer treatments,” said Rob Braun, President of GLC, a PA-based Jointly Accredited Provider. “This initiative will help clinicians stay up to date through innovative CME designed for the global care team.”
Evidence shows limitations of clinicians’ knowledge regarding the latest clinical data, lack of access to relevant resources, regional barriers to guidelines implementation, and a need for more concise education due to time constraints. Improving access to up-to-date science and education could improve patient outcomes.
“This initiative will address key barriers to high-quality cancer care that we see across the globe,” said Robert W. Carlson, MD, Chief Executive Officer, NCCN. “From improving the understanding of predictive biomarkers to personalizing treatment based on specific patient and tumor characteristics, we empower clinicians by providing evidence-based expert consensus recommendations and ensuring the patient care team has access to appropriate resources.”
More details regarding the collaboration can be obtained from Jorge Bacigalupo at the Global Learning Collaborative.
About Global Learning Collaborative
Global Learning Collaborative (GLC) is a member of the US HealthConnect Inc. group of CME companies. GLC is the parent organization to Omnia Education, Prova Education, Medtelligence, Medcon International, AXIS MedEd, TotalCME, MedEd On The Go, and the Academy for Global Interprofessional Learning & Education (AGILE). GLC develops, delivers, and measures CME/CE across a broad spectrum of diseases and clinical conditions for the entire healthcare team.
The National Comprehensive Cancer Network® (NCCN®) is a not-for-profit alliance of leading cancer centers devoted to patient care, research, and education. NCCN is dedicated to improving and facilitating quality, effective, equitable, and accessible cancer care so all patients can live better lives. Visit NCCN.org for more information on the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) and other initiatives. Follow NCCN on Facebook @NCCNorg, Instagram @NCCNorg and Twitter @NCCN.
Alicia A. Sutton
US HealthConnect Inc.
+1 (215) 237-5892